Hwang I, Kim JE, Jeong JH, Ahn JH, et al. Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in n Breast Cancer Res Treat 2023 Jun 26. doi: 10.1007/s10549-023-06971.
PMID: 37365483